The atrioventricular (AV) node conducts slowly and has a long refractory period. These features sustain the filtering of atrial impulses and hence are often modulated to optimize ventricular rate during supraventricular tachyarrhythmias. The AV node is also the site of a clinically common reentrant arrhythmia. Its function is assessed for a variety of purposes from its responses to a premature protocol (S 1S2, test beats introduced at different cycle lengths) repeatedly performed at different basic rates and/or to an incremental pacing protocol (increasingly faster rates). Puzzlingly, resulting data and interpretation differ with protocols as well as with chosen recovery and refractory indexes, and are further complicated by the presence of built-in fast and slow pathways. This problem applies to endocavitary investigations of arrhythmias as well as to many experimental functional studies. This review supports an integrated framework of rate-dependent and dual pathway AV nodal function that can account for these puzzling characteristics. The framework was established from AV nodal responses to S 1S2S3 protocols that, compared with standard S 1S2 protocols, allow for an orderly quantitative dissociation of the different factors involved in changes in AV nodal conduction and refractory indexes under rate-dependent and dual pathway function. Although largely based on data from experimental studies, the proposed framework may well apply to the human AV node. In conclusion, the rate-dependent and dual pathway properties of the AV node can be integrated within a common functional framework the contribution of which to individual responses can be quantitatively determined with properly designed protocols and analytic tools. atrioventricular node; functional assessment; conduction; refractory period; pretest cycle length; recovery; facilitation; fatigue THE ATRIOVENTRICULAR (AV) node generates a delay between atrial and His bundle activation that helps optimize ventricular filling and blood pumping. The AV node also has rate-dependent conduction and refractory properties accounting for the filtering of atrial impulses during supraventricular tachyarrhythmias. The optimization of this filtering to control the ventricular rate constitutes a cornerstone of atrial fibrillation therapy (3). Another consistent feature of the normal AV node is its built-in fast pathway (FP) and slow pathway (SP) (29, 36, 45, 50, 60, 73) . In some human hearts, SP and FP interplay to result in a clinical arrhythmia known as AV nodal reentrant tachycardia, the most common form of paroxysmal supraventricular tachycardia that can now be successfully cured by ablation therapy (24, 34, 59, 61) . These properties are obviously sensitive to autonomic tone (54 -57), itself modulated by conditions such as rest, exercise, pregnancy, stress, diseases, drugs, etc. However, the basic AV nodal physiology and its assessment tools remain debated. Their understanding is the primary goal of this review.
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The understanding of AV nodal function remains indeed challenging. Zipes borrowed a famous Churchill statement to aphoristically refer to the AV node as "a riddle wrapped in a mystery inside an enigma" (76) . Data characteristics and interpretation from functional studies remain particularly confounding despite progress made with mapping, immunohistochemistry, and imaging techniques (18, 23, 38, 42, 69) . One problem concerns discrepant changes in classical indexes of AV nodal refractoriness, effective refractory period (ERPN) and functional refractory period (FRPN), which are defined further below. Another puzzling issue concerns the absence of a definite relationship between AV nodal conduction and refractory properties (65) , in contrast to their presumed common involvement in atrial impulse filtering. Moreover, while the preceding recovery time is the primary determinant of AV nodal conduction time, its assessment with the preceding atrial cycle length or His-atrial interval yields different data when assessing rate-induced changes in AV nodal function. The same AV nodal responses to a given protocol, i.e., in the absence of a differing functional state, yield different data that support different conclusions depending upon the chosen re-covery index. This semantic disparity feeds a century-old controversy on the true nature of AV nodal function (5, 9, 19, 39, 41, 47, 53 ). An additional critical challenge is the manner in which the rate-dependent properties can coexist and be reconciled with dual pathways within the same AV node.
In this review, we recall classical concepts and tools used to assess AV nodal function, highlight associated problems, propose a functional and assessment framework overcoming these problems, and emphasize the relationship between rate-dependent properties of dual pathways and overall AV node. The discussed principles and assessment framework primarily rely on experimental data from rabbit hearts but may apply to human hearts as well and may be adapted to assess autonomic, drug, and pathological alterations of AV nodal function.
AV Nodal Preparation Landmarks and Sensing
The data supporting the proposed framework of AV nodal function were obtained from the classical rabbit heart preparation (27) . This preparation exhibits AV nodal properties analogous to those documented in human hearts (5, 62) , allows for a direct access to AV nodal inputs and output, and undergoes no extrinsic autonomic and humoral modulations (22) . It results from the opening of the right atrium and ventricle and removal of most of the left atrium, left ventricle, and right ventricle i.e., is composed of the right atrium and AV junction (Fig. 1A) . The preserved right atrium maintains an atrial activation and AV nodal input analogous to in situ physiology. The AV node occupies Koch's triangle (Fig. 1B) . The upper (atrial) and lower (ventricular) sides of the triangle correspond to the tendon of Todaro and tricuspid valve insertion, respectively. The His bundle and coronary sinus ostium provide its anterosuperior apex and posteroinferior base, respectively. The AV node contains substructures (transitional zone, posterior extension, compact node, and lower nodal bundle) that together contribute conduction times from which its properties are determined and thus are all included in its functional definition (7, 8, 17) . These substructures can be delineated with immunohistochemistry tools that can, among others, establish their distinct connexin distributions (18, 37, 69) . The connection between the transitional zone, compact node, and lower bundle provides a substrate for FP conduction (7, 60) . A connection between the septal portion of the transitional zone and lower nodal bundle bypassing the compact node has also been postulated as a FP substrate (48) . The posterior transitional zone, posterior extension, and lower bundle would together provide the substrate for SP conduction (50) . By connecting the atrium to the compact node and posterior extension, the transitional zone provides a common proximal pathway (7, 50) . The lower nodal bundle proximally connects to both the compact node and posterior extension and thereby provides a common distal pathway to the His bundle. The exact location where the dual pathways end and the common distal pathway starts remains yet unclear.
The sorting out of the role of each substructure in AV nodal functional responses would be ideal, but feasibility is limited by microscopic dimension, difficult access, complex anatomy and physiology, and experimental interference. Fortunately, the above-defined AV node (7, 8, 17) can be studied with the black box approach (Fig. 1C) . This simple approach is the only one applicable in clinical studies and remains abundantly used in functional and drug animal studies. With this approach, an unabridged AV node is studied from changes in the relationship between AV nodal input (A, atrial activation) and output (H, His bundle activation) induced by atrial stimulation paradigms. Atrial activation is typically sensed near the pacing site as well as from the crista terminalis and/or interatrial septum close to the entrance of the AV node with unipolar or bipolar surface electrodes (Fig. 1B) . Although the atrial pacing site greatly affects the resulting activation pattern, it does not affect AV nodal rate-dependent and dual pathway properties (1, 2) . Hence, the atrial activation pattern and sensed input, if constant during a study, have a negligible impact on AV nodal function assessment. However, atrial input characteristics may vary during arrhythmias such as atrial fibrillation and thereby affect resulting measurements (21) . The AV nodal conduction times illustrated in this review arose from upper atrial pacing and were measured from crista terminalis to His bundle unipolar signals (Fig. 1B) .
AV Nodal Function as Assessed with S 1 S 2 Protocols
The S 1 S 2 protocol (also called the premature or extrastimulus protocol) is widely used to assess AV nodal function in humans but also in experimental studies. This protocol involves a fixed number of constant basic S 1 S 1 cycles followed by a test S 1 S 2 premature cycle. The 1 and 2 subscripts mark basic and test events, respectively. An example of the resulting basic (BCL, A 1 A 1 ) and test (TCL, A 1 A 2 ) cycle length events is illustrated in Fig. 1D . This pacing sequence is repeated while maintaining S 1 S 1 constant and progressively reducing S 1 S 2 ( Fig. 2A ) until an S 2 beat initiates an atrial response but no His bundle activation i.e., results in an AV nodal block. The constant S 1 S 1 allows for each test beat to be assessed in a virtually constant steady state, a postulate that can be assessed from the pretest conduction time (A 1 H 1 ) i.e., the conduction time at the beat that precedes the test beat (Fig. 2B) . A recovery curve representing the recovery property can be constructed by plotting each test AV nodal conduction time (A 2 H 2 ) against the corresponding A 1 A 2 (Fig. 2B ). The curve typically shows an exponential-like A 2 H 2 increase with a flat and a steep portion in long and short A 1 A 2 ranges, respectively. Notably, the recovery time that is here assessed from A 1 A 2 constitutes the primary determinant of A 2 H 2 ; it increased A 2 H 2 by up to 100 ms in the data in Fig. 2B . The longest A 1 A 2 that does not induce a His bundle response yields ERPN. The shortest H 1 H 2 yields FRPN. While ERPN increases with basic rates (14, 16, 70) , FRPN shortens (13, 14, 16, 20, 25, 51) , so that the significance of these changes remains confounding. The dependence of A 2 H 2 on the preceding cycle length is similarly expressed at all BCL (41, 54, 66) . However, a short BCL (Fig. 2C) shifted the recovery curve upward and rightward compared with the control BCL (Fig. 2, D vs. B) . Two factors contribute to these shifts. One factor is the fatigue property that increases nodal conduction time with the magnitude and duration of the fast rate (11, 40, 41, 52) . Fatigue develops rapidly during the first minute of a fast rate and has usually reached a steady state after 5 min (11, 54) . Mean maximum fatigue measured in the flat portion of the curve increases A 2 H 2 by up to 12 ms in rabbit and dog hearts (11, 20, 41, 54) . Although fatigue remains to be selectively characterized in humans, it is expected to be analogous to that of other species (62) . The second factor is the prolongation of A 1 H 1 that results in a delay in the distal nodal cell activation and thereby recovery. An atrial activation with the same A 1 A 2 will thus be more premature when A 1 H 1 is increased and thus results in a prolonged A 2 H 2 . In the illustrated example ( Fig. 2D) (Fig. 2D ), a typical conflicting result leaving unanswered the question of whether refractoriness is then prolonged or curtailed.
Lewis and Master (41) promptly recognized the necessity to sort out fatigue and A 1 H 1 effects. They proposed using the electrocardiographic RP interval rather than the PP interval to assess the AV nodal recovery time. This approach as well as the His atrial interval assesses the AV nodal recovery time independently from A 1 H 1 . However, this approach underestimates the recovery time in the proximal portion of the AV node proportionally to the A 1 H 1 increase (19, 39, 47, 53) . Another means to limit the impact of A 1 H 1 increases on A 2 H 2 has been the insertion of a control cycle length between the last BCL and TCL (9, 11) . The long cycle allows for the return of A 1 H 1 to a value that differs from control only by fatigue effect, i.e., by a 12-ms average. The resulting recovery curve is then more uniformly shifted upward (11, 66) , i.e., primarily reflects fatigue effects.
Another property called facilitation contributes to BCLinduced changes in the recovery curve. The AV node conducts more rapidly than at control an impulse introduced with a short cycle length when the cycle length preceding the TCL is also short (41) . This phenomenon develops after a single short cycle and dissipates after a single long cycle (6) . Although obvious as a leftward curve shift when the recovery time is assessed from the preceding H 1 A 2 , facilitation is more difficult to identify when recovery is assessed from A 1 A 2 . On this basis, the very existence of AV nodal facilitation has been questioned (19, 47) . The true nature of facilitation is further obscured by the fact that it shortens FRPN and prolongs ERPN (10) .
In brief, the S 1 S 2 protocol is widely used and supports the identification of the recovery and fatigue properties but nonetheless suffers from limitations that confound the interpretation of conduction and refractory data. These limitations particularly arise from the effects of changing pretest conduction time on test beat events.
Rate-Dependent AV Nodal Function as Assessed with S 1 S 2 S 3 Protocols
S 1 S 2 S 3 protocols. The effects of increased pretest conduction time can be sorted out from recovery, facilitation, and fatigue properties with the use of S 1 S 2 S 3 protocols (64 -67). S 1 , S 2 , and S 3 mark the basic, pretest, and test stimulus, respectively. The same subscripts apply to resulting atrial (A) and His bundle (H) responses (Fig. 1E) . A 2 subscript here identifies a pretest event, while a 3 subscript identifies a test event. This protocol allows for the independent variation of the basic (BCL, A 1 A 1 ), pretest (PTCL, A 1 A 2 ), and test (TCL, A 2 A 3 ) cycle lengths. In our laboratory, we tested with a different S 1 S 2 S 3 protocol each of 30 paired combinations from 5 BCL and 6 PTCL (64 -67). In five protocols, BCL and PTCL were identical, thereby reproducing conditions similar to those prevailing during standard S 1 S 2 protocols performed at different basic rates where BCL and PTCL do not differ and are not distinguished. Thus our S 1 S 2 S 3 protocols allow for the sorting out of BCL and PTCL effects including some analogous to those resulting from S 1 S 2 protocols.
Four examples of S 1 S 2 S 3 protocols are displayed as S 1 S 1 , S 1 S 2 , and S 2 S 3 data points in Fig. 3 . They include the control protocol and protocols that induced maximal facilitation, fatigue, and combined facilitation and fatigue effects. The control protocol involves equal constant 360-ms S 1 S 1 and S 1 S 2 and progressively shorter S 2 S 3 (Fig. 3A) . The selective maximal facilitation effect was obtained while S 1 S 1 was maintained at its control value and S 1 S 2 was shortened to 135 ms before each S 2 S 3 (Fig. 3B) . The steady-state fatigue effect was determined after a 5-min 180-ms S 1 S 1 constant rhythm. The testing se- Fig. 3 . S1S1, S1S2, and S2S3 data points from the 4 S1S2S3 protocols used to characterize rate-dependent AV nodal function in 1 preparation. A: control S1S2S3 protocol in which S1S1 and S1S2 are equal and constant at 360 ms during S2S3 testing of the recovery property. B: selective facilitation S1S2S3 protocol. S1S1 remains at 360 ms, while S1S2 is shortened to a constant 135-ms value. C: selective fatigue S1S2S3 protocol. S1S1 is shortened to a constant 180-ms value while S1S2 is returned to its control 360-ms value before each S2S3 to dissipate facilitatory effects associated with the short S1S1. D: combined facilitation and fatigue S1S2S3 protocol. S1S1 is shortened to a constant 180-ms value and S1S2 to 135 ms. quence (Fig. 3C ) included one 360-ms S 1 S 2 that returned A 2 H 2 close to its control value and dissipated facilitation before the S 2 S 3 test. The combined maximal facilitation and fatigue effect was determined with a stimulation sequence made up of a 180-ms S 1 S 1 , a 135-ms S 1 S 2 , and a variable S 2 S 3 (Fig. 3D) .
Independent effects of BCL and PTCL on AV nodal recovery curve. The recovery curves (A 3 H 3 vs. A 2 A 3 ) resulting from the above four S 1 S 2 S 3 protocols are displayed in Fig. 4A . Importantly, the shape of the recovery curve only slightly varies with BCL and/or PTCL. However, both BCL and PTCL shortenings induce rightward and upward shifts of the recovery curve compared with the control. Maximal shifts occurred under combined BCL and PTCL shortenings (open squares in Fig.  4A) . Notably, even the facilitation protocol that involves a single short cycle, i.e., could not induce any fatigue, shifted the recovery curve rightward and upward in the short A 2 A 3 range as if affected by fatigue (open circles in Fig. 4A ). Our studies established that the degree of rightward shift of any recovery curve on the x-axis as assessed at constant 130-ms A 3 H 3 (dashed line in Fig. 4A ) linearly depends on the A 2 H 2 increase regardless of its BCL and/or PTCL origin (66) . Interestingly, Climent et al. (15) characterized AV nodal function with S 1 S 2 S 3 protocols equivalent to our PTCL-induced facilitation protocols and found that A 2 H 2 is then critical for a successful prediction of A 3 H 3 values. However, the A 2 H 2 -induced rightward shift was not self-evident at longest A 2 A 3 in Fig. 4A . This difficulty arose from the fact that the first tested S 2 S 3 ( Fig. 3) and thereby A 2 A 3 ( Fig. 4A) were identical in different protocols.
To further demonstrate that A 2 H 2 increases account for curve rightward shifts, we separately added each of the three A 2 H 2 increases from data in Fig. 4A as constants to A 2 A 3 values of the control curve (65) . Because fatigue and combined fatigue and facilitation protocols also shift the recovery curve upward, we determined the corresponding three A 3 H 3 increases at longest A 2 A 3 and added them as constants to control A 3 H 3 values. Calculated curves (Fig. 4B) largely reproduced changes observed in response to the three protocols (Fig. 4A) . This observation indicates that BCL-and/or PTCL-induced increases in A 2 H 2 bodily shifted the entire recovery curve proportionally rightward by a constant value while BCLinduced increase in A 3 H 3 bodily shifted the recovery curve upward by another constant.
Sorting out facilitation and fatigue effects from pretest effects. The A 2 H 2 -related rightward shift of the recovery curve causes A 3 H 3 to be longer at identical A 2 A 3 regardless of prevailing functional state. The contribution of this shift ought to be sorted out and taken into account in the assessment of both facilitation and fatigue. This can be effectively achieved in two ways. The first consists in correcting all A 2 A 3 for the A 2 H 2 increase (65). This correction caused otherwise diverging recovery curves (Fig. 4A ) to overlap over their flat portion at corresponding BCL, as expected from identical fatigue effects (Fig. 4C ). In the short corrected A 2 A 3 range, the BCL-and PTCL-induced rightward shifts with respect to the control curve completely disappeared. Only a leftward shift compatible with facilitatory effects affected the short A 2 A 3 ranges of the two recovery curves involving PTCL shortenings (open Fig. 4 . Effects of A2H2 increases on recovery curves. A: A3H3 vs. A2A3 recovery curves observed under control, facilitation, fatigue, and combined facilitation and fatigue protocols of Fig. 3 . B: calculated recovery curves obtained by adding a constant A2H2-related increase to all control A2A3 values and a constant fatigue-related increase to all control A3H3 values. Note similarity between curves in A and B. C: corrected recovery curves obtained by subtracting the increase in A2H2 (⌬A2H2) from A2A3 of curves displayed in A. D: observed recovery curves when the A3H3 displayed in A were plotted against corresponding observed H2A3. Note reduction of rightward shift and correspondence of curve shape in C and D despite distinct x-axes. The horizontal dashed line overlapping the recovery curves in A marks a constant 130-ms A3H3 and thereby the rightward shift undergone by the recovery curves. Reproduced from Journal of Cardiovascular Electrophysiology (65) with permission. circles and squares in Fig. 4C ). The second way to free fatigue and facilitation data from A 2 H 2 increases consists in plotting A 3 H 3 against H 2 A 3 (Fig. 4D) . Despite their distinct x-axes, the observed H 2 A 3 -based curve (Fig. 4D ) and corrected recovery curve (Fig. 4C ) yield virtually identical fatigue and facilitation effects. Because it is constructed from direct measurements rather than calculations, the H 2 A 3 -based curve may perhaps offer a net advantage. Yet, because A 2 A 3 is an easily accessible variable in clinical settings, it may be practical to use it with the appropriate A 2 H 2 -based correction. In the absence of His bundle recordings, the ventricular signal may be used as a surrogate. Thus different recovery indexes yield identical AV nodal recovery, facilitation, and fatigue properties provided that A 2 H 2 changes are taken into account in their assessment (66) . In our understanding, these two formats of A 2 H 2 -free changes in recovery curves equally and adequately reflect genuine changes in rate-dependent AV nodal conduction.
Effects of pretest conduction time on refractory periods. Increases in A 2 H 2 also affected ERPN measurements. Because ERPN is the longest A 2 A 3 that does not induce a His bundle response and corresponds to an A 2 H 2 ϩ H 2 A 3 sum (Fig. 1E) , it undergoes the same A 2 H 2 -induced rightward shift as the whole recovery curve and thus is accordingly prolonged (65) . This occurs regardless of whether the A 2 H 2 prolongation is caused by BCL and/or PTCL shortenings. FRPN (shortest H 2 H 3 or sum of H 2 A 3 ϩ A 3 H 3 ) is by definition insensitive to A 2 H 2 -induced rightward shift of the recovery curve. The consideration of A 2 H 2 effects on ERPN allowed us to establish a new relationship between ERPN and FRPN. As expected from classical discordant effects of basic rate on refractory indexes, our raw ERPN and FRPN data did not correlate whatsoever (Fig. 5A) . Conversely, FRPN values closely correlated with ERPN values corrected for A 2 H 2 increases as studied with 30 protocols in each of 6 preparations (Fig. 5B) . ERPN and FRPN similarly increased with BCL and decreased with PTCL effects (64) . This also applied to identical BCL and PTCL shortenings as occurring during increased basic rates of the standard S 1 S 2 protocol. Although FRPN and corrected ERPN occur at different H 2 A 3 values, these values varied in parallel under BCL and PTCL effects (unpublished observations). In brief, BCL-and PTCL-induced changes in ERPN and FRPN are closely related when associated changes in pretest conduction time are taken into account in their assessment. Specifically, BCL shortening prolongs refractoriness, while PTCL shortening curtails it.
Physiology and Assessment of Transient AV Nodal Responses
The above data from S 1 S 2 S 3 protocols were obtained in steady-state conditions as assessed from A 1 H 1 (66) and/or A 2 H 2 (65) low variability. The question then arises of whether rules established from steady-state responses apply to transient responses. Do recovery, fatigue, and facilitation properties established in steady-state conditions also account for transient rate-dependent AV nodal function? There is evidence that this is effectively the case, although the contribution from the three AV nodal properties then varies over time. For instance, these properties account for transient responses to linear ramp increase and decrease in cycle length inducing hysteresis in AV nodal conduction time (12, 75) . These properties also quantitatively account for a variety of other rate-induced AV nodal responses including Wenckebach cycles (54, 62, 68, 74) . A recent study also provides analytical and modeling data supporting their involvement in human supraventricular tachyarrhythmias (46) . Factors contributing to the wide variety of transient AV nodal responses can be appreciated from the following three examples.
S 1 S 2 S 3 protocols. An example of the effects of transient changes in functional state during S 1 S 2 S 3 protocols on recovery curves is illustrated in Fig. 6 . The control S 1 S 2 S 3 protocol was performed at steady-state constant 400-ms BCL and PTCL (filled circles in Fig. 6 ). A second S 1 S 2 S 3 protocol was performed at constantly shortened 175-ms BCL (8 basic beats) and an identical 175-ms PTCL while testing the first S 3 at the beginning of the protocol and rapidly decrementing the TCL (open circles in Fig. 6 ). Conversely to that seen during steadystate conditions (Fig. 4 ), fatigue and A 2 H 2 effects then concurrently developed during the protocol and accordingly prolonged A 3 H 3 of beats tested with increasingly shorter A 2 A 3 (Fig. 6) . A third S 1 S 2 S 3 protocol also was performed at the constant 175-ms BCL-PTCL combination, but the BCL number was increased to 20 and TCL was decremented more slowly (filled squares in Fig. 6 ). These two changes increased the time at which any A 2 A 3 occurred after the beginning of the protocol so that A 3 H 3 were longer over the entire A 2 A 3 range compared with the protocol with eight basic beats (Fig. 6) . Associated ERPN and FRPN values (not shown) also varied with functional state. Thus transient changes in the functional state during S 1 S 2 S 3 protocols markedly affect the resulting recovery curve and thereby the assessment of rate-dependent AV nodal conduction and refractory properties.
Incremental pacing protocol. This widely used protocol involves stepwise decreases in atrial cycle length and aims at establishing WCL, i.e., the cycle length at which AV nodal blocks of the Wenckebach type develop. Some insight into factors controlling these AV nodal responses is provided by comparing them with those from S 1 S 2 S 3 protocols in the same preparation. The AH obtained at the end of each constant pacing sequence of an incremental protocol (20-ms shortening every 40th beat) are plotted against atrial cycle length (Fig. 7A) . The resulting curve is displayed together with two S 1 S 2 S 3 -based steady-state curves, one obtained at control and one at identical short BCL and PTCL in one preparation. The AH from the incremental protocol first overlaps the control curve and then increases to reach values close to those from the short BCL-PTCL. Although the contribution of AV nodal properties during the incremental protocol remains to be sorted out, resulting AH suggest that, as pacing cycle length was reduced, the fatigue level increased from null to a maximum reached in the short interstimulus interval (SS) range. A effect similar to the pretest effect, i.e., an AH increase with the preceding one, was also likely involved during the incremental protocol in the short SS range. When A 2 H 2 effects in S 1 S 2 S 3 responses and their equivalent in the incremental protocol were eliminated by using the His-atrial interval as the recovery index, all three curves converge in the short His-atrial range (Fig. 7B) . This likely occurred because of the mutual cancellation of fatigue and facilitation effects from both protocols over this range.
Constant fast rate. Another particularly intriguing example of transient AV nodal responses was obtained at a constant pacing interval and fatigue level (Fig. 8) . In this experiment (67), the preparation was subjected to a constant short 170-ms SS for 5 min during which a long 350-ms SS (slightly shorter than spontaneous atrial cycle length) was intercalated after every 30th short SS. The AH from the long cycle length rapidly increased during the first minute of pacing and reached a steady state after ϳ2 min, then reflecting a constant fatigue level. However, the constant SS and constant fatigue did not prevent a beat-to-beat increase in AH from occurring in a repetitive consistent manner after each long SS. This likely occurred because each AH increase curtailed the AV nodal recovery Fig. 7 . Superimposed AV nodal responses to S1S2S3 and incremental pacing protocols. A: recovery curves obtained with an S1S2S3 protocol performed at control, with an S1S2S3 protocol performed at equal short BCL and PTCL, and with an incremental pacing protocol. The latter was obtained by plotting the AH interval at the last beat of each constant 40-beat SS sequence against the preceding AA. The cycle length was slowly reduced in 5-ms steps. Note the iteration of the incremental pacing curve from the control to the fast pacing curve arising from S1S2S3 protocol. B: His-atrial interval-based recovery curves from same data as in A. Note curve convergence in short His-atrial interval range. time at the next beat that further increased the AH and so on until the long cycle occurred and reset the system. Anyhow, these transient responses were highly organized and reproducible, suggesting that they obey very specific rules.
The above three examples of transient AV nodal responses suggest that, despite their diversity, they share a common origin in the recovery, fatigue, and facilitation properties as for other rate-induced responses. However, further studies with specifically designed protocols will be necessary for the quantification of the role of each of these properties in these responses.
Dual Pathway Origin of Rate-Dependent AV Nodal Function
Growing evidence supports the concept that the rate-dependent properties of SP and FP together account for those of the overall AV node. Although they share some common features, these dual pathways must be distinguished from those of patients suffering from AV nodal reentrant tachycardia. The typical signature of dual pathways in these patients is a broken recovery curve, i.e., a sudden Ͼ50-ms "jump" of AV nodal conduction time when conduction shifts from FP to SP under a 10-ms S 1 S 2 decrease (61). In these patients, FP conduction prevails over long and intermediate cycle length ranges but, because of its long refractory period, fails over the short cycle length range. Because of its short refractory period, the SP can conduct over this range and initiate a retrograde activation of recovered FP, thereby causing a reentrant atrial beat. Selfperpetuated atrial reentry results in an AV nodal reentrant tachycardia. This arrhythmia can now be cured with ablation therapy of either pathway (24, 31, 32, 35) . However, easiest access, greater success rate, and lower complication incidence have established the SP as a preferred target.
Normal dual pathways are observed in human, rabbit, porcine, and canine hearts (4, 26, 28, 30, 36, 43, 49, 50, 60, 71) and show FP and SP conduction ranges and refractory periods analogous to those of patients suffering from an AV nodal reentrant tachycardia. However, the normal dual pathways yield a smoother recovery curve at the transition from FP to SP than that of these patients (36, 50, 60) . They can nonetheless be interrupted with ablation lesions (4, 26, 36, 43, 44, 60, 71) . The typical target of a SP ablation is the crista terminalis input to the AV node, while the target of FP ablation is the interatrial septum input. The dimension of resulting successful lesions typically reaches several millimeters.
SP conduction can also be interrupted in rabbit heart preparations with microlesions applied to the posterior extension (Fig. 9, inset) as located from the timing and shape of endocardial surface unipolar electrograms (36, 43, 44, 50, 60) . Such a SP ablation typically prevents conduction over the short H 2 A 3 range and prolongs ERPN during a control S 1 S 2 S 3 protocol (Fig. 9) . The SP ablation similarly affects the recovery curve resulting from the facilitation protocol (open circles and squares in Fig. 9 ). Because of the amputated steep rising portion of the curve, no significant level of facilitation can then be detected. Conversely, the close overlap of A 3 H 3 values obtained before and after SP ablation in the long and intermediate H 2 A 3 ranges indicates that baseline conduction through the FP remains virtually unchanged after SP ablation in both protocols.
Microlesions applied between transitional and compact node tissues (Fig. 10, inset) consistently interrupt FP (44, 60) . FP ablation prolongs conduction time over the long and intermediate H 2 A 3 ranges by a 16-ms average during the control protocol but minimally affects conduction over the short H 2 A 3 range (filled circles and squares in Fig. 10 ). ERPN is not significantly affected, either (44, 60) . Conduction then occurs through SP over all H 2 A 3 ranges including the long range. The facilitation protocol induces a typical tilting of the curve to the left both before and after the FP ablation (Fig. 10) , indicating that FP ablation does not affect the facilitation property. The effects of SP and FP ablation on the fatigue property remain to be determined. However, the fact that a short BCL similarly prolongs conduction over the entire H 2 A 3 range (Fig. 4D) suggests that SP and FP are equally sensitive to fatigue. The His electrogram alternans also supports the dual pathway origin of the recovery property (72) . Bipolar recordings taken from the inferior portion of the lower nodal bundle during a premature protocol show a small-amplitude signal during the FP conduction portion of the recovery curve and a severalfold increased signal during SP conduction. Importantly, this approach provides a tool to monitor dual pathway function during arrhythmias such as Wenckebach cycles and atrial fibrillation (71, 73) . It may become a useful tool to further explore the relationship between rate-dependent and dual pathway function.
In brief, the recovery property is contributed to by the FP and SP in the long and short H 2 A 3 ranges, respectively. A posterior extension ablation prevents SP conduction. After a FP ablation, SP conduction occurs over the entire cycle length range. The absence of facilitation after SP ablation and its persistence after FP ablation indicate that facilitation mainly depends on SP. Fatigue would equally prolong FP and SP conduction time, and thus would accordingly prolong the overall AV nodal conduction time. These results suggest that the normal recovery, facilitation, and fatigue properties of FP and SP account for those of the overall normal AV node.
Clinical Implications
The proposed functional framework provides an upgraded conceptual background for the design and interpretation of studies on rate-dependent and dual pathway function. An improved knowledge of AV nodal rate-dependent properties may help understanding of conduction phenomena observed in electrophysiological studies during atrial arrhythmia or programmed atrial pacing protocols. An integrated understanding of rate-dependent properties and dual pathway physiology may also assist in developing and interpreting pacing maneuvers performed for diagnostic purposes in patients with supraventricular tachyarrhythmias (33, 58, 63) . The integrated understanding of rate-dependent and dual pathway physiology is critical to interpretation of AV nodal behavior before and after ablation in patients suffering from AV nodal reentrant tachycardia. An obvious first step toward the application of our framework in humans will be a direct demonstration that it applies to normal and perturbed human heart function.
The S 1 S 2 S 3 protocols can be applied to assess specific aspects of AV nodal function, but, obviously, the 30 protocols used to establish the characteristics of the recovery, facilitation, and fatigue properties (64 -67) need not be repeated in all studies. For instance, the overall profile of conduction and refractory variation limits can be established with four protocols (Figs. 3 and 4) . Whatever the protocol combination used, the recovery time will remain the primary determinant of AV nodal function and its accurate assessment will require the consideration of pretest effects. This is made necessary by the fact that any increase in A 2 H 2 regardless of its BCL or PTCL origin shifts the whole recovery curve rightward and thereby bias conduction and refractory measurements. This problem can be easily overcome by correcting the recovery curve for A 2 H 2 increases (Fig. 4C and Fig. 5B ) or by using H 2 A 3 as a recovery index (Fig. 4D) . The disparity problem between ERPN and FRPN in their capacity to reflect AV nodal refractoriness can also be solved by correcting ERPN for A 2 H 2 increases (Fig. 5) .
Another consideration that may have clinical implications is steady-state assessment from changes in AV nodal conduction time at basic beats. Transient changes in functional state can have profound effects and result in a wide variety of challenging responses even in the absence of autonomic modulations (Figs. 6, 7, and 8) . Determination of stability level may help to interpret responses occurring over time. For instance, some levels of autonomic modulations may render the determination of small-dimension facilitation and fatigue irrelevant in a clinical setting. Protocols could then be limited to those targeting recovery-dependent changes in AV nodal function.
Conclusions
Our review supports a comprehensive functional framework and assessment scheme of integrated rate-dependent and dual pathway AV nodal function. It supports the concept that individual rate-dependent properties of FP and SP account for those of the overall AV node. The backbone of the rate-dependent behavior of the AV node is provided by its recovery, fatigue, and facilitation properties that can be rigorously and independently assessed with S 1 S 2 S 3 protocols performed in steady-state conditions and allowing the assessment of pretest effects. These properties also provide the backbone for transient rate-induced AV nodal responses, but the sorting out of their roles is then more complicated, yet feasible. Our assessment scheme may also apply to the characterization of autonomic and pharmacological modulation of the AV node, but this will require specifically designed studies. Although largely based on data from experimental studies, the proposed framework may well apply to the human AV node. In brief, the rate-dependent and dual pathway properties of the AV node can be integrated within a common functional framework the contribution of which to individual responses can be quantitatively determined with properly designed protocols and analytic tools.
